Hyeon Ji Lee , Hyeon-Joong Kim , Soon Seong Choi , Hye Jeong Choo , Hee Jae Huh , Eun Jeong Won
{"title":"AllplexTM stx1/2/2a/2d分型(ASTXT)检测对产志贺毒素大肠杆菌诊断和分型的评价","authors":"Hyeon Ji Lee , Hyeon-Joong Kim , Soon Seong Choi , Hye Jeong Choo , Hee Jae Huh , Eun Jeong Won","doi":"10.1016/j.diagmicrobio.2024.116645","DOIUrl":null,"url":null,"abstract":"<div><div>This study assessed the performance of the Allplex<sup>TM</sup> stx1/2/2a/2d Typing (ASTXT) assay (Seegene) for diagnosis and typing Shiga toxin-producing <em>Escherichia coli.</em> Analytical sensitivity and specificity were evaluated using 18 spiked strains, and cross-reactivity was tested on 114 strains including <em>E. coli</em> without Shiga toxin. Clinical performance was evaluated using the proficiency panels and 76 stool samples. Analytical sensitivity was revealed to 4.14 log<sub>10</sub> CFU ml<sup>−1</sup> for <em>E. coli</em> strain with <em>stx1</em>, 4.47 log<sub>10</sub> CFU ml<sup>−1</sup> for strain with <em>stx2,</em> 4.03 log<sub>10</sub> CFU ml<sup>−1</sup> for strain with <em>stx2a,</em> and 4.02 log<sub>10</sub> CFU ml<sup>−1</sup> for strain with <em>stx2d,</em> respectively. Imprecisions were within 5 % and cross-reactivity was not observed. The ASTXT assay showed perfect agreement with the proficiency panel results and achieved 100 % positive and negative percent agreement using clinical stool samples. The ASTXT assay demonstrated reliable performance for the rapid detection and typing of Shiga toxin-producing <em>E. coli</em> in human stool samples.</div></div>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"111 3","pages":"Article 116645"},"PeriodicalIF":2.1000,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of the AllplexTM stx1/2/2a/2d Typing (ASTXT) assay for the diagnosis and typing of Shiga toxin-producing Escherichia coli\",\"authors\":\"Hyeon Ji Lee , Hyeon-Joong Kim , Soon Seong Choi , Hye Jeong Choo , Hee Jae Huh , Eun Jeong Won\",\"doi\":\"10.1016/j.diagmicrobio.2024.116645\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>This study assessed the performance of the Allplex<sup>TM</sup> stx1/2/2a/2d Typing (ASTXT) assay (Seegene) for diagnosis and typing Shiga toxin-producing <em>Escherichia coli.</em> Analytical sensitivity and specificity were evaluated using 18 spiked strains, and cross-reactivity was tested on 114 strains including <em>E. coli</em> without Shiga toxin. Clinical performance was evaluated using the proficiency panels and 76 stool samples. Analytical sensitivity was revealed to 4.14 log<sub>10</sub> CFU ml<sup>−1</sup> for <em>E. coli</em> strain with <em>stx1</em>, 4.47 log<sub>10</sub> CFU ml<sup>−1</sup> for strain with <em>stx2,</em> 4.03 log<sub>10</sub> CFU ml<sup>−1</sup> for strain with <em>stx2a,</em> and 4.02 log<sub>10</sub> CFU ml<sup>−1</sup> for strain with <em>stx2d,</em> respectively. Imprecisions were within 5 % and cross-reactivity was not observed. The ASTXT assay showed perfect agreement with the proficiency panel results and achieved 100 % positive and negative percent agreement using clinical stool samples. The ASTXT assay demonstrated reliable performance for the rapid detection and typing of Shiga toxin-producing <em>E. coli</em> in human stool samples.</div></div>\",\"PeriodicalId\":11329,\"journal\":{\"name\":\"Diagnostic microbiology and infectious disease\",\"volume\":\"111 3\",\"pages\":\"Article 116645\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-12-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diagnostic microbiology and infectious disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0732889324004693\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic microbiology and infectious disease","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0732889324004693","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Evaluation of the AllplexTM stx1/2/2a/2d Typing (ASTXT) assay for the diagnosis and typing of Shiga toxin-producing Escherichia coli
This study assessed the performance of the AllplexTM stx1/2/2a/2d Typing (ASTXT) assay (Seegene) for diagnosis and typing Shiga toxin-producing Escherichia coli. Analytical sensitivity and specificity were evaluated using 18 spiked strains, and cross-reactivity was tested on 114 strains including E. coli without Shiga toxin. Clinical performance was evaluated using the proficiency panels and 76 stool samples. Analytical sensitivity was revealed to 4.14 log10 CFU ml−1 for E. coli strain with stx1, 4.47 log10 CFU ml−1 for strain with stx2, 4.03 log10 CFU ml−1 for strain with stx2a, and 4.02 log10 CFU ml−1 for strain with stx2d, respectively. Imprecisions were within 5 % and cross-reactivity was not observed. The ASTXT assay showed perfect agreement with the proficiency panel results and achieved 100 % positive and negative percent agreement using clinical stool samples. The ASTXT assay demonstrated reliable performance for the rapid detection and typing of Shiga toxin-producing E. coli in human stool samples.
期刊介绍:
Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology, the journal examines new procedures, unusual cases, controversial issues, and important new literature. Diagnostic Microbiology and Infectious Disease distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.